Fracture risk associated with use of nonsteroidal anti-inflammatory drugs, acetylsalicylic acid, and acetaminophen and the effects of rheumatoid arthritis and osteoarthritis
about
Single dose oral lumiracoxib for postoperative painFaecal blood loss with aspirin, nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors: systematic review of randomized trials using autologous chromium-labelled erythrocytes.The Trend-in-trend Research Design for Causal Inference.Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health InitiativeRepeated vertebral augmentation for new vertebral compression fractures of postvertebral augmentation patients: a nationwide cohort study.Knee arthroplasty and risk of hip fracture: a population-based, case-control studySpinal and paraspinal lesions: the role of stereotactic body radiotherapy.A randomised controlled trial of low-dose aspirin for the prevention of fractures in healthy older people: protocol for the ASPREE-Fracture substudyAcetylsalicylic acid combined with diclofenac inhibits cartilage degradation in rabbit models of osteoarthritis.Current status of adult spinal deformity.Proton pump inhibitors use and change in bone mineral density.Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS).Effect of reproductive history, lactation, first pregnancy age and dietary habits on bone mineral density in natural postmenopausal women.Metabolic Bone Disease in Gastrointestinal Disorders
P2860
Q24242935-170CE2DC-0EDD-4398-8A3F-746ED4ABA40DQ30481876-81EB6F28-EF94-4B38-AFD5-2459D668945DQ30846561-9AADDA9A-7FE7-48A5-B7C4-95FA6A2BB087Q34554705-7A1EA1D5-F239-46F0-9D98-E9861B5881FFQ35240296-AE450D57-03C1-4F59-8288-97F544EA1F74Q35730282-32313836-E362-4F9D-B5A2-7428BB068F22Q36887077-66E3834E-6582-4A53-8EA3-8DA7E0A478FFQ36932652-5DE42423-A24A-4124-97A3-85C24052C489Q37288600-1DFF38C4-C7C8-458D-8788-EB44637409E0Q37376297-F2327B20-3F6F-4D6F-BF80-C798B02D497BQ39724310-F43930CE-7B5E-4741-A288-D919D95A0584Q50554046-58038F18-F692-4565-954A-5605D51D33A0Q50954294-0AD337BC-5AA5-49A0-8704-B67015670DEFQ57169423-C36B1788-9A30-48D8-A102-57B8353D83B6
P2860
Fracture risk associated with use of nonsteroidal anti-inflammatory drugs, acetylsalicylic acid, and acetaminophen and the effects of rheumatoid arthritis and osteoarthritis
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Fracture risk associated with ...... d arthritis and osteoarthritis
@ast
Fracture risk associated with ...... d arthritis and osteoarthritis
@en
Fracture risk associated with ...... d arthritis and osteoarthritis
@nl
type
label
Fracture risk associated with ...... d arthritis and osteoarthritis
@ast
Fracture risk associated with ...... d arthritis and osteoarthritis
@en
Fracture risk associated with ...... d arthritis and osteoarthritis
@nl
prefLabel
Fracture risk associated with ...... d arthritis and osteoarthritis
@ast
Fracture risk associated with ...... d arthritis and osteoarthritis
@en
Fracture risk associated with ...... d arthritis and osteoarthritis
@nl
P921
P1476
Fracture risk associated with ...... d arthritis and osteoarthritis
@en
P2093
Mosekilde L
Vestergaard P
P2860
P2888
P356
10.1007/S00223-006-0020-8
P407
P577
2006-08-15T00:00:00Z
P5875
P6179
1052773424